Answers are grounded in this paper and cite their sources.
Nanoparticles have attracted considerable attention owing to their broad range of applications. Surface functionalization further expands their functionality, making them useful in fields such as biomedicine, catalysis, sensing, and environmental remediation. In such applications, nanoparticles may form clusters through aggregation under high ionic-strength conditions, while biologically derived nanoparticles can be intrinsically heterogeneous in size. In this study, we apply small-angle neutron scattering (SANS) and small-angle X-ray scattering (SAXS) to nanoparticles and use Bayesian inference to analyze their heterogeneous particle-size distributions. Because SAXS and SANS probe the wavevector dependence of the static scattering intensity, they can sensitively resolve two distinct particle sizes even when a small fraction (< 10%) of larger particles is mixed with smaller particles. We construct multimodal particle-size distribution models within a Bayesian framework and demonstrate the importance of model selection for accurately estimating heterogeneous particle-size distributions. This approach should be broadly applicable to nanoparticle characterization across a wide range of applications.
No takes yet. Share an insight, caveat, or question.
Yin et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: